ArticleFrontiers in oncology2025

How to predict progression-free survival in patients with grade 2 IDH-mutated diffuse gliomas after surgery: a long-term follow-up analysis.

Marta Aprile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.